Novugen Pharma Sdn Bhd

About Novugen Pharma Sdn Bhd

Novugen Pharma Sdn. Bhd. is a wholly-owned subsidiary company of a UAE-based group, SciTech International. With over 30 years of experience in the healthcare industry, the company is equipped with vast and successful experience in venturing into strategic healthcare businesses and developing world-class healthcare facilities around the globe. Novugen’s passion for science, bold global strategy, and wealth of international experience prepared us to respond to the complex challenges of bringing hard-to-source and technology-intensive products to the market while maintaining affordable pricing and rigorous quality assurance. Novugen specializes in highly technical generics for all oncology and general medicine therapeutic areas while meeting strict global quality standards. Highly driven to challenge the status quo, Novugen is committed to providing early access to affordable medicine with the highest quality in the world. We are the first pharmaceutical company in ASEAN to be vertically integrated with our line of business from API and Finished Product R&D, manufacturing to commercialization, giving us greater control over the supply chain. As a technology leader, we create efficiency by integrating our total value chain. The people behind our science and business are teams working synergistically to innovate new concepts to accelerate the launch of pharmaceuticals that lack robust generic alternatives due to their complexity. Our vision is to be the most significant and fastest-growing pharmaceutical company in Southeast Asia by 2025, competing in global markets.